Premium
Five‐year outcomes of a personalized pro re nata treatment regimen with anti‐vascular endothelial growth factor for neovascular age‐related macular degeneration
Author(s) -
Stattin Martin,
Forster Julia,
Graf Alexandra,
Ahmed Daniel,
Krebs Ilse,
AnsariShahrezaei Siamak
Publication year - 2019
Publication title -
acta ophthalmologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.534
H-Index - 87
eISSN - 1755-3768
pISSN - 1755-375X
DOI - 10.1111/aos.13840
Subject(s) - pro re nata , macular degeneration , medicine , ranibizumab , aflibercept , ophthalmology , diabetic retinopathy , visual acuity , choroidal neovascularization , bevacizumab , regimen , diabetes mellitus , surgery , chemotherapy , endocrinology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom